Enanta Pharmaceuticals logo
Enanta Pharmaceuticals ENTA
$ 9.31 2.53%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Enanta Pharmaceuticals Financial Ratios 2011-2024 | ENTA

Annual Financial Ratios Enanta Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -0.0 -0.0 25.8 19.7 53.4 20.9 6.6 23.5 20.3 - -

P/S

0.0 0.0 0.0 0.0 5.8 6.9 9.2 5.1 3.3 17.0 6.1 - -

EPS

-6.4 -5.9 -3.9 -1.8 2.4 3.7 0.9 1.1 4.2 1.9 -0.7 1.3 1.4

EV (Enterprise Value)

160 M 11 M -16.4 M -55.6 M 1.17 B 1.38 B 904 M 448 M 513 M 787 M 193 M -2.28 M 151 M

EBITDA per Share

-6.43 K -5.87 K -5.27 K -1.91 K 2.04 4.72 1.4 1.72 6.68 1.05 0.945 - -

EV/EBITDA

-13.1 -20.6 28.6 14.9 32.9 13.4 4.0 40.3 20.1 - -

PEG

0.0 0.0 0.0 0.0 -0.7 0.07 -2.9 -0.29 0.05 0.06 -0.14 - -

P/B

0.0 0.0 0.0 0.0 2.6 3.6 3.1 1.7 2.2 5.5 1.8 - -

P/CF

-0.0 -0.0 -0.0 0.1 18.1 54.1 18.8 14.6 7.1 42.3 19.4 - -

ROE %

-61.74 -37.89 -19.78 -7.94 10.03 18.28 5.87 8.03 33.45 23.17 8.71 - -

ROA %

-28.95 -32.43 -18.00 -7.44 9.47 17.37 5.42 7.70 32.11 22.16 8.23 - -

ROCE %

-63.31 -38.54 -27.43 -9.14 7.86 22.18 8.05 11.28 51.88 12.60 8.03 - -

Current Ratio

1.9 6.9 11.1 15.9 17.8 23.7 11.3 29.4 25.5 22.8 23.1 - -

DSO

66.7 93.0 88.5 111.5 91.3 118.7 37.7 53.1 35.7 34.4 18.1 - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

66.7 93.0 88.5 111.5 - - - - - - - - -

Cash Conversion Cycle

66.7 93.0 88.5 111.5 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Enanta Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.07 -1.47 -1.58 - -1.86 -1.79 -1.39 -4.64 -1.53 -1.63 -1.48 -2.7 -1.19 -1.09 -0.41 -1.46 -0.71 -0.41 0.68 0.47 0.36 0.68 1.34 1.41 1.05 1.34 0.61 1.91 -0.44 0.61 -0.26 -0.09 -0.06 -0.26 1.39 0.3 0.13 1.39 2.26 -0.27 2.7 2.26 -0.3 -0.25 -0.23 -0.3 1.61 -4.78 -4.31 2.41 -4.44 - - -

EBITDA per Share

- - -1.62 - - - -1.42 -4.54 -1.57 -1.65 -1.45 -3.64 -1.59 -1.47 -0.57 -0.96 -1.05 -0.57 0.7 1.67 0.27 0.7 1.47 2.9 1.24 1.47 0.78 -1.48 -0.63 0.78 -0.34 1.86 -0.02 -0.34 1.91 6.48 0.11 1.91 3.78 1.34 1.89 3.78 -0.3 1.97 -0.23 -0.3 18.9 23.7 -3.06 29.5 - - - -

ROE %

-67.81 -69.02 -64.24 -40.04 -69.73 -62.68 -58.07 -56.27 -40.20 -36.57 -32.26 -26.27 -14.48 -10.57 -7.36 -2.73 1.89 6.52 11.15 14.46 17.76 21.07 24.38 21.96 27.97 19.08 16.67 11.13 -1.64 0.76 -4.77 7.00 10.13 11.55 24.48 36.26 30.41 63.05 80.22 53.45 52.82 15.41 -17.72 -9.12 -1.58 5.20 6.55 6.55 3.04 - - - - -

ROA %

-28.90 -31.11 -35.11 -27.77 -53.18 -53.52 -50.24 -48.74 -35.72 -32.82 -29.59 -24.49 -13.80 -10.18 -6.87 -2.51 1.95 6.41 10.86 13.96 17.49 21.03 24.56 22.27 27.17 18.31 15.61 10.39 -1.43 0.77 -4.58 6.61 9.62 10.98 23.40 33.49 27.88 59.11 75.49 51.12 50.56 14.82 -16.80 -19.69 -23.66 -26.84 -14.48 -14.48 -6.71 - - - - -

ROCE %

-69.58 -68.78 -63.70 -40.06 -70.18 -64.37 -59.17 -57.10 -45.97 -44.44 -41.81 -36.62 -22.43 -19.39 -15.30 -9.91 1.18 7.01 12.40 16.26 22.60 27.12 30.98 28.98 6.52 -3.14 -5.14 -12.29 10.12 14.07 6.93 23.03 61.47 62.59 80.28 103.05 68.39 91.14 123.30 81.89 77.96 50.71 -1.46 -18.30 -52.73 -45.89 -18.95 -18.95 3.06 - - - - -

Current Ratio

1.6 1.7 1.8 1.9 1.9 5.7 7.4 6.9 8.2 8.4 7.8 11.2 13.8 11.2 16.6 15.9 15.9 15.9 17.8 17.9 17.9 17.9 16.6 20.2 20.2 20.2 14.7 13.1 13.1 13.1 27.3 24.8 24.8 24.8 19.7 25.0 25.0 25.0 9.9 23.0 23.0 23.0 24.1 18.0 18.0 18.0 - 6.3 6.3 - - - - -

DSO

40.5 42.6 42.5 - 88.6 103.5 83.0 27.6 89.5 113.0 84.5 28.1 95.4 125.4 79.4 90.7 114.9 109.3 90.2 91.2 105.5 105.2 89.5 91.2 107.1 93.5 40.4 12.8 128.9 107.1 101.9 91.2 83.8 134.5 31.2 96.8 120.3 86.6 46.1 59.7 3.7 1.2 55.5 54.7 44.7 41.3 1.7 51.5 18.8 - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

40.5 42.6 42.5 - 88.6 103.5 83.0 27.6 89.5 113.0 84.5 28.1 95.4 125.4 79.4 90.7 114.9 109.3 90.2 91.2 105.5 105.2 89.5 91.2 107.1 93.5 40.4 12.8 128.9 107.1 101.9 91.2 83.8 134.5 31.2 96.8 120.3 86.6 46.1 59.7 3.7 1.2 55.5 54.7 44.7 41.3 1.7 51.5 18.8 - - - - -

Cash Conversion Cycle

40.5 42.6 42.5 - 88.6 103.5 83.0 27.6 89.5 113.0 84.5 28.1 95.4 125.4 79.4 90.7 114.9 109.3 90.2 91.2 105.5 105.2 89.5 91.2 107.1 93.5 40.4 12.8 128.9 107.1 101.9 91.2 83.8 134.5 31.2 96.8 120.3 86.6 46.1 59.7 3.7 1.2 55.5 54.7 44.7 41.3 1.7 51.5 18.8 - - - - -

All numbers in USD currency